A prospective contralateral-eye study has found that trabecular micro-bypass surgery with the iStent inject significantly improves signs and symptoms of...
Read moreDetailsA real-world study of Chinese children and adolescents has concluded that RLRL therapy provides promising long-term efficacy and safety in...
Read moreDetailsMore than one million people in the UK are currently living with glaucoma, almost 50% higher than previous estimates, according...
Read moreDetailsChedy Kalach, a director and senior teacher at the Australasian College of Optical Dispensing, is urging everyone in the optical...
Read moreDetailsResearchers at the OHSU Casey Eye Institute have developed the world’s first handheld ultra-widefield optical coherence tomography (OCT) system for...
Read moreDetailsA recent study suggests that levodopa, a common Parkinson’s disease medication, may reduce the risk of progression from early-stage age-related...
Read moreDetailsResearchers in the United States are advancing a groundbreaking stem-cell retinal implant for people with advanced dry age-related macular degeneration...
Read moreDetailsEssilorLuxottica has announced new clinical findings from two studies, including one in Australia, evaluating the performance of Nuance Audio glasses,...
Read moreDetailsA research collaboration between the John A. Moran Eye Center’s Intermountain Ocular Research Center (IORC) and cataract surgeon Dr Morgan...
Read moreDetailsNew research has revealed that despite an evolving clinical understanding of glaucoma, many ophthalmologists continue to rely on the historical...
Read moreDetails
Insight has been the leading industry publication in Australia for more than 40 years. This longevity is largely due to our ability to consistently deliver accurate and independent news relevant to all ophthalmic professionals and their supporting industry.
© 2026 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited
© 2026 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited